LDLR and neoplasm: Our results demonstrated widespread LDLR expression in the majority of the adult GBM cases with intra-tumour variation noted and a similar paediatric expression pattern which was independent of tumour grade, confirming LDLR as a valid therapeutic target across all ages for malignant glioma.